Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hercules Technology Growth Capital (NY: HTGC )

18.87 -0.05 (-0.26%)
Official Closing Price Updated: 7:00 PM EST, Nov 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Hercules Technology Growth Capital

< Previous 1 2 3 4 Next >
Disc Medicine Secures $200 Million in Non-Dilutive Debt Financing from Hercules Capital, Inc.
From Disc Medicine Inc
Via GlobeNewswire
Hercules Capital Reports Third Quarter 2024 Financial Results
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Declares a Total Cash Distribution of $0.48 per Share for the Third Quarter 2024
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Announces Date for Release of Third Quarter 2024 Financial Results and Conference Call
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Receives Reaffirmed Baa3 Investment Grade Rating with Revised Outlook to Positive from Moody’s Investors Service
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Announces Upcoming Event for the Financial Community
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Receives a BBB+ Reaffirmed Investment Grade Corporate Rating from Kroll Bond Rating Agency, Inc.
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Reports Second Quarter 2024 Financial Results
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Declares a Total Cash Distribution of $0.48 Per Share for the Second Quarter 2024
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Announces Date for Release of Second Quarter 2024 Financial Results and Conference Call
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Receives SBA Approval for Its Fourth SBIC License
From Hercules Capital, Inc.
Via Business Wire
Adaptimmune Secures up to $125 Million Debt Financing with Hercules Capital
Philadelphia, Pennsylvania and Oxford, United Kindgom--(Newsfile Corp. - May 15, 2024) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company redefining... 
Via Newsfile
Hercules Capital Announces Date of 2024 Annual Meeting of Stockholders
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Announces Upcoming Event for the Financial Community
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Reports First Quarter 2024 Financial Results
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Declares a Total Cash Distribution of $0.48 per Share for the First Quarter 2024
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Celebrates 20th Anniversary with $20.0 Billion in Cumulative Originations
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Announces Date for Release of First Quarter 2024 Financial Results and Conference Call
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Receives BBB- Affirmed Investment Grade Credit and Corporate Rating from Fitch Ratings, Inc.
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Receives Confirmed BBB Investment Grade Rating with Revised Outlook to Positive from Morningstar DBRS
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Announces Upcoming Event for the Financial Community
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Reports Fourth Quarter and Full-Year 2023 Financial Results
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Declares a Total Cash Distribution of $0.48 per Share for the Fourth Quarter 2023
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Announces New Supplemental Cash Distribution of $0.32 per Share
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2023 Financial Results and Conference Call
From Hercules Capital, Inc.
Via Business Wire
Phathom Pharmaceuticals Announces Expansion of Existing Loan and Security Agreement with Hercules Capital
From Phathom Pharmaceuticals
Via GlobeNewswire
Hercules Capital Receives SBA “Green Light” Letter to Submit Its Fourth SBIC License Application
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Announces Upcoming Events for the Financial Community
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Reports Third Quarter 2023 Financial Results
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Declares a Total Cash Distribution of $0.48 per Share for the Third Quarter 2023
From Hercules Capital, Inc.
Via Business Wire
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.